DOI: 10.1055/s-00000036

Laryngo-Rhino-Otologie

References

Seiwert TY. et al.
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial.

Lancet Oncol 2016;
17: 956-965

Download Bibliographical Data

Search in:
Access: